Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 4, 2012, Pages

  Arvold, Nils D ^a   Niemierko, Andrzej ^b   Broussard, George P ^b   Adams, Judith ^b   Fullerton, Barbara ^b   Loeffler, Jay S ^b   Shih, Helen A ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Benign meningioma; Neurocognitive; Photon radiotherapy; Proton radiotherapy; Second tumor risk

Indexed keywords

BENIGN MENINGIOMA; BRAINSTEM; CRITICAL STRUCTURES; EQUIVALENT UNIFORM DOSE; INTRACRANIAL MENINGIOMA; MASSACHUSETTS; NEUROCOGNITIVE; NORMAL TISSUE COMPLICATION PROBABILITIES; OPTIC NERVE; ORGANS AT RISKS; PHOTON RADIOTHERAPY; PITUITARY GLAND; PROTON RADIOTHERAPY; TEMPORAL LOBES; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY; TOTAL DOSE; TREATMENT PLANS;

AUDITION; BRAIN; EYE PROTECTION; PHOTONS; PROTONS; RADIOTHERAPY; RISKS; TUMORS;

THREE DIMENSIONAL;

ARTICLE; BRAIN; BRAIN STEM; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL ARTICLE; COCHLEA; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; HIPPOCAMPUS; HUMAN; HYPOPHYSIS; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MENINGIOMA; NEUROANATOMY; OPTIC NERVE; PHOTON THERAPY; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION INDUCED NEOPLASM; RADIOLOGICAL PARAMETERS; SECOND CANCER; TEMPORAL LOBE;

BRAIN; COCHLEA; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; OPTIC NERVE; ORGAN SPARING TREATMENTS; ORGANS AT RISK; PHOTONS; PITUITARY GLAND; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RISK;

EID: 84862651938     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.10.056     Document Type: Article

References (20)

1. Central Brain Tumor Registry of the United States. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2004-2007. Available at: http://www.cbtrus.org/2011-NPCR-SEER/WEB- 0407-Report-3-3-2011.pdf. Accessed May 15th, 2011.
2. Tanzler E, Morris CG, Kirwan JM, et al. Outcomes of WHO Grade I meningiomas receiving definitive or postoperative radiotherapy. Int J Radiat Oncol Biol Phys 2011;79:508-513.
3. Noël G, Bollet MA, Calugaru V, et al. Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons. Int J Radiat Oncol Biol Phys 2005;62:1412-1422.
4. Jalali R, Mallick I, Dutta D, et al. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy. Int J Radiat Oncol Biol Phys 2010;77:974-979.
5. Pai HH, Thornton A, Katznelson L, et al. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2001;49:1079-1092.
6. Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006;98:1528-1537.
7. Wenkel E, Thornton AF, Finkelstein D, et al. Benign meningioma: Partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys 2000;48:1363-1370.
8. Baumert BG, Norton IA, Lomax AJ, et al. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions. Int J Radiat Oncol Biol Phys 2004;60:1314-1324.
9. Bolsi A, Fogliata A, Cozzi L. Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: A treatment planning study. Radiother Oncol 2003;68:1-14.
10. Winkfield KM, Niemierko A, Bussiere MR, et al. Modeling intracranical second tumor risk and estimates of clinical toxicity with various radiation therapy techniques for patients with pituitary adenoma. Technol Cancer Res Treat 2011;10:243-251.
11. Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 2002;53:407-421.
12. Schneider U, Zwahlen D, Ross D, et al. Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose. Int J Radiat Oncol Biol Phys 2005;61:1510-1515.
13. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). UNSCEAR 2000 report, volume II: Sources and effects of ionizing radiation. Available at: http://www.unscear.org/unscear/en/publications/2000-2. html. Accessed May 15th, 2011.
14. Niemierko A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 1997;24:103-110.
15. Gay HA, Niemierko A. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy. Phys Med 2007;23:115-125.
16. Brada M, Rajan B, Traish D, et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol 1993;38:571-578.
17. Athar BS, Paganetti H. Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans. Radiother Oncol 2011;98:87-92.
18. Ris MD, Packer R, Goldwein J, et al. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: A Children's Cancer Group study. J Clin Oncol 2001;19:3470-3476.
19. Mulhern RK, Kepner JL, Thomas PR, et al. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduce-dose craniospinal irradiation: A Pediatric Oncology Group study. J Clin Oncol 1998;16:1723-1728.
20. Mahajan A, Dong L, Prabhu S, et al. Application of deformable image registration to hippocampal doses and neurocognitive outcomes (Abstr.). Soc Neuro-Oncol 2007;9:538.